During the past decade, Yarosslavl Clinical Hospital #3 conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yarosslavl Clinical Hospital #3" are "Bioequivalence" (4 trials) and "Pharmacokinetics" (1 trials). Many other conditions were trialed in "Yarosslavl Clinical Hospital #3" in a lesser frequency.

Most popular intervention types in "Yarosslavl Clinical Hospital #3" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Metformin" (2 trials), "GP30101" (1 trials), "Glucophage®" (1 trials), "Glucophage® Long" (1 trials) and "Humulin NPH" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yarosslavl Clinical Hospital #3" are 2 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Yarosslavl Clinical Hospital #3". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Yarosslavl Clinical Hospital #3, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yarosslavl Clinical Hospital #3, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".